These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 28980476)

  • 21. LSVT-BIG therapy in Parkinson's disease: physiological evidence for proprioceptive recalibration.
    Peterka M; Odorfer T; Schwab M; Volkmann J; Zeller D
    BMC Neurol; 2020 Jul; 20(1):276. PubMed ID: 32652957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of exercise on motor and nonmotor symptoms of Parkinson's disease.
    Dashtipour K; Johnson E; Kani C; Kani K; Hadi E; Ghamsary M; Pezeshkian S; Chen JJ
    Parkinsons Dis; 2015; 2015():586378. PubMed ID: 25722915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Task-Based LSVT-BIG Intervention on Hand Function, Activity of Daily Living, Psychological Function, and Quality of Life in Parkinson's Disease: A Randomized Control Trial.
    Choi Y; Kim D
    Occup Ther Int; 2022; 2022():1700306. PubMed ID: 36133576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comment on 'Lee Silverman Voice Treatment (LSVT)-BIG to improve motor function in people with Parkinson's disease: a systematic review and meta-analysis'.
    Braun T; Marks D; Thiel C
    Clin Rehabil; 2018 Sep; 32(9):1284-1285. PubMed ID: 29644881
    [No Abstract]   [Full Text] [Related]  

  • 25. Lee Silverman Voice Treatment for people with Parkinson's: audit of outcomes in a routine clinic.
    Wight S; Miller N
    Int J Lang Commun Disord; 2015; 50(2):215-25. PubMed ID: 25469736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non-inferiority trial.
    Constantinescu G; Theodoros D; Russell T; Ward E; Wilson S; Wootton R
    Int J Lang Commun Disord; 2011; 46(1):1-16. PubMed ID: 21281410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Practitioner perspectives on the implementation of the Lee Silverman Voice Treatment BIG® program.
    Botkin L; Proffitt R
    Clin Park Relat Disord; 2024; 11():100268. PubMed ID: 39234492
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of robot-assisted gait training on motor impairments in people with Parkinson's disease: a systematic review and meta-analysis.
    Alwardat M; Etoom M; Al Dajah S; Schirinzi T; Di Lazzaro G; Sinibaldi Salimei P; Biagio Mercuri N; Pisani A
    Int J Rehabil Res; 2018 Dec; 41(4):287-296. PubMed ID: 30119060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidimensional voice assessment after Lee Silverman Voice Therapy (LSVT
    Marchese MR; Proietti I; Longobardi Y; Mari G; Ausili Cefaro C; D'Alatri L
    Acta Otorhinolaryngol Ital; 2022 Aug; 42(4):348-354. PubMed ID: 36254651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect on Gait Speed, Balance, Motor Symptom Rating, and Quality of Life in Those with Stage I Parkinson's Disease Utilizing LSVT BIG®.
    Millage B; Vesey E; Finkelstein M; Anheluk M
    Rehabil Res Pract; 2017; 2017():9871070. PubMed ID: 28331638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of Ai Chi on balance, quality of life, functional mobility, and motor impairment in patients with Parkinson's disease.
    Kurt EE; Büyükturan B; Büyükturan Ö; Erdem HR; Tuncay F
    Disabil Rehabil; 2018 Apr; 40(7):791-797. PubMed ID: 28084851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physiotherapy versus placebo or no intervention in Parkinson's disease.
    Tomlinson CL; Patel S; Meek C; Clarke CE; Stowe R; Shah L; Sackley CM; Deane KH; Herd CP; Wheatley K; Ives N
    Cochrane Database Syst Rev; 2012 Jul; (7):CD002817. PubMed ID: 22786482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The JFK BIG study: the impact of LSVT BIG
    Isaacson S; O'Brien A; Lazaro JD; Ray A; Fluet G
    J Phys Ther Sci; 2018 Apr; 30(4):636-641. PubMed ID: 29706722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of LSVT® BIG on standing balance in a Parkinson's patient: A case report.
    Iwai M; Koyama S; Takeda K; Hirakawa Y; Motoya I; Kumazawa N; Sakurai H; Kanada Y; Kawamura N; Kawamura M; Tanabe S
    Physiother Res Int; 2021 Oct; 26(4):e1921. PubMed ID: 34482577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of the Lee Silverman Voice Treatment BIG® on motor symptoms in a participant with progressive supranuclear palsy: A case report.
    Hirakawa Y; Takeda K; Koyama S; Iwai M; Motoya I; Sakurai H; Kanada Y; Kawamura N; Kawamura M; Tanabe S
    Physiother Theory Pract; 2024 Sep; 40(9):2171-2178. PubMed ID: 37326324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of the gait improvement effect of LSVT BIG® using a wearable sensor in patients with Parkinson's disease.
    Matsuno A; Matsushima A; Saito M; Sakurai K; Kobayashi K; Sekijima Y
    Heliyon; 2023 Jun; 9(6):e16952. PubMed ID: 37332954
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.
    Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ
    Am J Speech Lang Pathol; 2007 May; 16(2):95-107. PubMed ID: 17456888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effects of Lee Silverman Voice Treatment on daily voice use in Parkinson's disease as measured with a portable voice accumulator.
    Körner Gustafsson J; Södersten M; Ternström S; Schalling E
    Logoped Phoniatr Vocol; 2019 Oct; 44(3):124-133. PubMed ID: 29447488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of physical exercise on reaction time in patients with Parkinson's disease-data from the Berlin BIG Study.
    Ebersbach G; Ebersbach A; Gandor F; Wegner B; Wissel J; Kupsch A
    Arch Phys Med Rehabil; 2014 May; 95(5):996-9. PubMed ID: 24231400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of Lee Silverman Voice Treatment (LSVT LOUD®) on voice, communication, and participation: Findings from a prospective, longitudinal study.
    Bryans LA; Palmer AD; Anderson S; Schindler J; Graville DJ
    J Commun Disord; 2021; 89():106031. PubMed ID: 33259945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.